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Background:  Atrial fibrillation (AF) is a common co-morbidity in heart failure patients treated with cardiac resynchronization therapy (CRT). History 
of AF or new episodes of AF after CRT implantation may have a role in determining the outcome in the long-term.
Methods:  Aim of the present study was to evaluate the incidence of hospitalization for cardiac cause or life threating ventricular arrhythmias in 
patients implanted with a CRT device with defibrillator backup, during a two-year follow-up.
Results:  Four-hundred-six patients were implanted with CRT with defibrillator backup for primary prevention of sudden death and enrolled in the 
ACTION-HF study (male gender: 79%; ischemic aetiology 48%; age 68±9; QRS duration 157±32; ejection fraction: 26±6). One-hundred and fifteen 
patients (28%) had history of AF, 55 of whom permanent. New onset atrial arrhythmias occurred in 67 patients (17%). During the the follow up 47 
patients died, 160 events of hospitalization for cardiac cause (80 due to heart failure) occurred in 118 patients and 123 patients experienced 
at least one episode of sustained ventricular tachycardia. According to a multivariate Cox model including the baseline patient characteristics, 
AF history was a strong and independent predictor of the combination of all-cause mortality or cardiac cause hospitalization (HR: 3.3; p<0.001) 
and of ventricular arrhythmias (HR: 1.7; P=0.004). Additionally a new onset of AF, independently from previous history of AF, was associated the 
development of mortality or cardiac hospitalizations (HR: 3.0 p<0.001) and ventricular arrhythmias (HR: 3.4 p<0.001).
Conclusions:  In this group of CRT patients, history of AF and new onset of AF after device implantation are common and strongly associated with 
the occurrence of cardiac events, including heart failure or ventricular arrhythmias. AF may play an important role in determining the response to CRT 
and in the management of heart failure patients.
